Key result
Obesity linked to ~22% lower mortality in diabetes, but not in coronary heart disease.
Cohort
Yes
Answers are grounded in this paper and cite their sources.
Observes that smoking status modifies adiposity-mortality relationships in chronic illness, indicating confounding in the obesity paradox.
OBJECTIVE: The obesity paradox in which overweight/obesity is associated with mortality benefits is believed to be explained by confounding and reverse causality rather than by a genuine clinical benefit of excess body weight. We aimed to gain deeper insights into the paradox through analyzing mortality relationships with several adiposity measures; assessing subgroups with type 2 diabetes, with coronary heart disease (CHD), with cancer, and by smoking status; and adjusting for several confounders. RESEARCH DESIGN AND METHODS: = 45,790) at baseline. A range of adiposity exposures were considered, including BMI (continuous and categorical), waist circumference, body fat percentage, and waist-to-hip ratio, and the outcome was all-cause mortality. We used Cox regression models adjusted for age, smoking status, deprivation index, education, and disease history. RESULTS: For BMI, the obesity paradox was observed among people with type 2 diabetes (adjusted hazard ratio for obese vs. normal BMI 0.78 [95% CI 0.65, 0.95]) but not among those with CHD (1.00 [0.86, 1.17]). The obesity paradox was pronounced in current smokers, absent in never smokers, and more pronounced in men than in women. For other adiposity measures, there was less evidence for an obesity paradox, yet smoking status consistently modified the adiposity-mortality relationship. CONCLUSIONS: The obesity paradox was observed in people with type 2 diabetes and is heavily modified by smoking status. The results of subgroup analyses and statistical adjustments are consistent with reverse causality and confounding.
No takes yet. Share an insight, caveat, or question.
Jenkins et al. (2018) conducted a cohort in Type 2 diabetes, coronary heart disease, and cancer. Adiposity measures (obese BMI, waist circumference, body fat percentage, waist-to-hip ratio) vs. Normal BMI was evaluated on All-cause mortality (HR 0.78, 95% CI 0.65-0.95). Obese versus normal BMI was associated with lower mortality in type 2 diabetes but not in CHD, heavily modified by smoking.
Synapse has enriched 10 related papers. Consider them for comparative context: